Leukemia test kit HEMASALUS™

for lymphomafor myelomaoncology

DNA sequencing alone or in combination with RNA sequencing can provide valuable insight to the key genetic features involved in hematologic malignancies, especially alterations that may be less common or those that provide an opportunity for targeted therapy. We offer pan-cancer panels designed to help identify the most suitable treatment for patients with hematologic malignancies. Comprehensive genomic profiling for all hematologic malignancies  Hemasalus™ analyses mutations and selected translocations of 475 key genes in hematologic malignancies by targeted DNA-sequencing (Hemasalus™ D), or in combination with whole transcriptome mRNA-sequencing (Hemasalus™ DR) to detect a broader range of gene translocations and expression changes. WHO IS IT FOR Patients with hematologic malignancies SAMPLE TYPES FOR LYMPHOMAS Tumor tissue (FFPE block/slides, or frozen tissue) Fine needle biopsy